Bleeding Risk in Atrial Fibrillation: HAS-BLED Score
Understand the risk of bleeding from anticoagulation in atrial fibrillation
The HAS-BLED score was derived from a real-world cohort of 3978 with AF and assesses the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease >2 g/L, and/or transfusion) associated with oral anticoagulation. Patients with a high risk of bleeding (HAS-BLED score ≥ 3) should undergo regular clinical review following the initiation of oral anticoagulation.
- [1]Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY.: A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.Chest 2010, 138 (5): 1093-100
Results
Real-time automated computation
The HAS-BLED score was derived from a real-world cohort of 3978 with AF and assesses the 1-year risk for major bleeding (intracranial, hospitalization, hemoglobin decrease >2 g/L, and/or transfusion) associated with oral anticoagulation. Patients with a high risk of bleeding (HAS-BLED score ≥ 3) should undergo regular clinical review following the initiation of oral anticoagulation.
- [1]Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY.: A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.Chest 2010, 138 (5): 1093-100